Infant Bacterial Therapeutics AB (publ) announced Interim Management Statement second quarter and six months ended June 30, 2019. For the quarter, the company reported Operating loss was SEK 7,973,000 against profit of SEK 1,286,000 a year ago. Loss after tax was SEK 7,561,000 against profit of SEK 665,000 a year ago. Loss per share before and after dilution were SEK 0.67 against earnings of SEK 0.06 a year ago. For the six months, the company reported Operating loss was SEK 8,766,000 against SEK 7,858,000 a year ago. Loss after tax was SEK 8,247,000 against SEK 8,479,000 a year ago. Equity per share was SEK 48.86 against SEK 52.54 a year ago. Loss per share before and after dilution were SEK 0.73 against SEK 0.82 a year ago.